The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

FDA approves glucose weight loss monitoring app. Aside from dieting, there are alternatives to losing weight. This includes ...

The Food and Drug Administration approved the first-ever glucose monitoring system specifically for weight management from ...

The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

Palo Alto, California-based Signos integrated the Dexcom Stelo OTC continuous glucose monitor (CGM) with an AI-powered ...

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...

The system, from Signos, offers three- and six-month plans ($139 and $129 a month, respectively), and the company will send all of the continuous glucose monitors a patient needs, CNBC reported. Plus: ...

The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose mo ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ever-growing popularity of Eli Lilly's Zepbound and Novo Nordisk's Wegovy.

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.